PE20100139A1 - Nuevas n-(2-amino-fenil)-acrilamidas - Google Patents

Nuevas n-(2-amino-fenil)-acrilamidas

Info

Publication number
PE20100139A1
PE20100139A1 PE2009000647A PE2009000647A PE20100139A1 PE 20100139 A1 PE20100139 A1 PE 20100139A1 PE 2009000647 A PE2009000647 A PE 2009000647A PE 2009000647 A PE2009000647 A PE 2009000647A PE 20100139 A1 PE20100139 A1 PE 20100139A1
Authority
PE
Peru
Prior art keywords
phenyl
amino
acrylamide
pyrrolidin
methyl
Prior art date
Application number
PE2009000647A
Other languages
English (en)
Inventor
Jason Christopher Wong
Xihan Wu
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PE20100139A1 publication Critical patent/PE20100139A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/08—Bridged systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

SE REFIERE A COMPUESTOS DERIVADOS DE N-(2-AMINO-FENIL)-ACRILAMIDA DE FORMULA (I), DONDE R1 ES H, AQLUILO INFERIOR, CICLOALQUILO, ARILO, ENTRE OTROS; R2, R3 Y R4 SON CADA UNO H, HALO, ALQUILO INFERIOR, ENTRE OTROS. SON COMPUESTOS SELECCIONADOS: (E)-N-(2-AMINO-FENIL)-3-{4-[(4-CICLOPROPIL-FENILCARBAMOIL)-((S)-3-HIDROXI-PIRROLIDIN-1-IL)-METIL]-FENIL}-ACRILAMIDA; (E)-N-(2-AMINO-FENIL)-3-{4-[(4-CLORO-FENILCARBAMOIL)-(3-DIETILAMINO-PIRROLIDIN-1-IL)-METIL]-FENIL}-ACRILAMIDA; (E)-N-(2-AMINO-FENIL)-3-{4-[(4-BROMO-FENILCARBAMOIL)-((S)-3-HIDROXI-PIRROLIDIN-1-IL)-METIL]-FENIL}-ACRILAMIDA; ENTRE OTROS. TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA Y A SU PROCEDIMIENTO DE PREPARACION. DICHOS COMPUESTOS SON INHIBIDORES DE LA HISTONA DESACETILASA (HDAC), UTLES EN EL TRATAMIENTO DE ENFERMEDADES COMO EL CANCER EN SERES HUMANOS Y ANIMALES
PE2009000647A 2008-05-16 2009-05-12 Nuevas n-(2-amino-fenil)-acrilamidas PE20100139A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08156365 2008-05-16

Publications (1)

Publication Number Publication Date
PE20100139A1 true PE20100139A1 (es) 2010-03-05

Family

ID=40756614

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2009000647A PE20100139A1 (es) 2008-05-16 2009-05-12 Nuevas n-(2-amino-fenil)-acrilamidas

Country Status (15)

Country Link
US (1) US7999000B2 (es)
EP (1) EP2280940A1 (es)
JP (1) JP2011519966A (es)
KR (1) KR20100132553A (es)
CN (1) CN102026969A (es)
AR (1) AR071790A1 (es)
AU (1) AU2009248231A1 (es)
BR (1) BRPI0912399A2 (es)
CA (1) CA2724003A1 (es)
CL (1) CL2009001150A1 (es)
IL (1) IL208873A0 (es)
MX (1) MX2010012297A (es)
PE (1) PE20100139A1 (es)
TW (1) TW200951110A (es)
WO (1) WO2009138338A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8202866B2 (en) * 2008-09-17 2012-06-19 Hoffmann-La Roche Inc. Ortho-aminoanilides for the treatment of cancer
JP2012518612A (ja) * 2009-02-23 2012-08-16 エフ．ホフマン−ラ ロシュ アーゲー ガンの治療のための新規なオルトアミノアミド類
US9212132B2 (en) 2011-12-05 2015-12-15 Ricoh Company Ltd. (Meth)acrylic acid ester, activation energy ray curing composition, and inkjet recording ink
US9834520B2 (en) 2013-03-14 2017-12-05 Takeda Pharmaceutical Company Limited Heterocyclic compound
EP3018126A4 (en) 2013-07-03 2016-12-07 Takeda Pharmaceuticals Co HETEROCYCLIC COMPOUND
EP3018123B1 (en) 2013-07-03 2023-05-10 Takeda Pharmaceutical Company Limited Amide compound

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1033046B (it) 1970-10-31 1979-07-10 Finotto Martino Procedimento di fabbricazione di benzimidazoli sostituiti
DE2201062A1 (de) * 1972-01-11 1973-07-26 Bayer Ag N-alkoxycarbonyl- bzw. n-alkylthiocarbonyl-2-(2'-thienyl)-benzimidazole, ein verfahren zu ihrer herstellung und ihre verwendung als fungizide
CA2391952C (en) * 1999-11-23 2012-01-31 Methylgene Inc. Inhibitors of histone deacetylase
EP1429765A2 (en) * 2001-09-14 2004-06-23 Methylgene, Inc. Inhibitors of histone deacetylase
US7253204B2 (en) * 2004-03-26 2007-08-07 Methylgene Inc. Inhibitors of histone deacetylase
EP1874295A4 (en) * 2005-04-20 2009-08-12 Merck & Co Inc benzothiophene
EP1973405A4 (en) 2006-01-12 2011-06-01 Merck Sharp & Dohme HYDROXYALKYMARYLAMIDE DERIVATIVES
JP2009528354A (ja) * 2006-02-28 2009-08-06 メルク エンド カムパニー インコーポレーテッド ヒストン脱アセチル化酵素のインヒビター
CA2711995A1 (en) * 2008-01-29 2009-08-06 F. Hoffmann-La Roche Ag Novel n-(2-amino-phenyl)-amide derivatives

Also Published As

Publication number Publication date
US20090286848A1 (en) 2009-11-19
CL2009001150A1 (es) 2010-06-11
IL208873A0 (en) 2011-01-31
US7999000B2 (en) 2011-08-16
AU2009248231A1 (en) 2009-11-19
MX2010012297A (es) 2010-12-06
TW200951110A (en) 2009-12-16
KR20100132553A (ko) 2010-12-17
WO2009138338A1 (en) 2009-11-19
BRPI0912399A2 (pt) 2016-01-12
AR071790A1 (es) 2010-07-14
CA2724003A1 (en) 2009-11-19
JP2011519966A (ja) 2011-07-14
CN102026969A (zh) 2011-04-20
EP2280940A1 (en) 2011-02-09

Similar Documents

Publication Publication Date Title
EA200971084A1 (ru) 5-членные гетероциклические амиды и родственные соединения
EA201100299A1 (ru) Органические соединения
BR112012017123A2 (pt) composto de n-(1h-indazol-4-il)imidazo [1,2-a]piridina-3-carboxamida como inibidores de cfms
PE20110367A1 (es) DERIVADOS DE 4-CIANO-4-FENIL-PIRROLIDIN-2-CARBOXAMIDAS SUSTITUIDAS COMO INHIBIDORES DE LA INTERACCION p53-MDM2
EA201291356A1 (ru) Пиперидиноновые производные как ингибиторы mdm2 для лечения рака
PE20090772A1 (es) Derivados de bencimidazol
EA200900959A1 (ru) Ингибиторы мек
EA201270546A1 (ru) ЗАМЕЩЕННЫЕ ПИПЕРИДИНЫ, КОТОРЫЕ ПОВЫШАЮТ АКТИВНОСТЬ p53, И ИХ ПРИМЕНЕНИЕ
CO6612267A2 (es) Nuevos derivados de 1,1 dióxido- 5 fenil- 2,3,4-5tetrahidro- 1,4-benzotiazepina y composiciones farmaceúticas que los comprenden
PE20100139A1 (es) Nuevas n-(2-amino-fenil)-acrilamidas
EA201300684A1 (ru) Производные 6-амино-2-фениламино-1н-бензимидазол-5-карбоксамида и их применение в качестве ингибиторов микросомной простагландин-е2-синтазы-1
EA201290078A1 (ru) Гетероциклические соединения для ингибирования pask
EA201100049A1 (ru) Органические соединения
EA201270560A1 (ru) Спиропиперидиновые соединения и их фармацевтическое применение для лечения диабета
NZ596579A (en) Bace inhibitors
EA201100691A1 (ru) Антагонисты рецепторов лизофосфатидной кислоты
EA201100136A1 (ru) 2,4'-бипиридинилы в качестве ингибиторов протеинкиназы d, применимые для лечения сердечной недостаточности и рака
EA201101618A1 (ru) Арилпиридины в качестве ингибиторов альдостеронсинтазы
EA200901583A1 (ru) N-(2-(гетарил)арил)арилсульфонамиды и n-(2-(гетарил)гетарил)арилсульфонамиды
PE20070531A1 (es) Compuestos heterociclicos como inhibidores de aspartil proteasas
BR112012007747A2 (pt) Compostos heterocíclicos úteis como inibidores de pdk1, sua composição farmacêutica e seus usos
BRPI0911035B8 (pt) ativadores de pirrolidinona glicoquinase
EA201290103A1 (ru) Гетероциклические соединения и их использование
PE20091400A1 (es) Derivados de n-(2-amino-fenil)-amida como inhibidores de hdac
EA201290416A1 (ru) Новые спиропиперидиновые соединения

Legal Events

Date Code Title Description
FD Application declared void or lapsed